Table 1.
Demographics of Persons Who Received HCV Antibody Testing and HCV Treatment Prescriptions
| Variables | HCV antibody testing by year, age, sex |
HCV treatment prescriptions by year, age, sex |
||||
|---|---|---|---|---|---|---|
| 2018 (March‒July), | 2019 (March‒July), | 2020 (March‒July), | 2018 (January‒July), | 2019 (January‒July), | 2020 (January‒July), | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Age, years | ||||||
| Unknown | 1,493 (0.1) | 1,253 (0.1) | 737 (0.1) | — | — | — |
| 0‒19 | 78,639 (3.8) | 82,813 (4.0) | 56,797 (3.9) | 470 (0.3) | 482 (0.3) | 605 (0.5) |
| 20‒39 | 789,686 (37.8) | 831,065 (40.6) | 625,175 (43.1) | 26,240 (14.1) | 31,963 (19.0) | 31,968 (24.1) |
| 40‒59 | 693,239 (33.2) | 659,700 (32.2) | 452,357 (31.2) | 75,091 (40.4) | 65,798 (39.0) | 50,729 (38.2) |
| 60‒84 | 514,717 (24.6) | 463,625 (22.6) | 308,215 (21.2) | 83,392 (44.9) | 69,730 (41.4) | 49,126 (37.0) |
| ≥85 | 10,742 (0.5) | 10,096 (0.5) | 7,594 (0.5) | 518 (0.3) | 542 (0.3) | 292 (0.2) |
| Sex | ||||||
| Female | 1,180,244 (56.5) | 1,156,144 (56.4) | 847,386 (58.4) | 70,828 (38.2) | 64,836 (38.5) | 51,200 (38.6) |
| Male | 902,867 (43.2) | 886,914 (43.3) | 599,938 (41.4) | 114,467 (61.8) | 103,390 (61.5) | 81,460 (61.4) |
| Unknown | 5,405 (0.3) | 5,494 (0.3) | 3,551 (0.2) | — | — | — |
| Total | 2,088,516 (100.0) | 2,048,552 (100.0) | 1,450,875 (100.0) | 185,295 (100.0) | 168,226 (100.0) | 132,660 (100.0) |
HCV, Hepatitis C virus.